Documentation Centre

 

 

  of 103 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393:407-415 July 12, 2019 Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393:407-415 Cholesterol Treatment Trialists' Collaboration Key Publications
Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year Framingham score. Hepatology. 2019;69:1453-1463 July 09, 2019 Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year Framingham score. Hepatology. 2019;69:1453-1463 Pais R, Redheuil A, Cluzel P, Ratziu V, Giral P Key Publications
The interplay between nonalcoholic fatty liver disease and atherosclerotic heart disease. Hepatology. 2019;69:1372-1374 July 08, 2019 The interplay between nonalcoholic fatty liver disease and atherosclerotic heart disease. Hepatology. 2019;69:1372-1374 Patel SS, Siddiqui MS Key Publications
The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study. Atherosclerosis. 2019;282:154-161 June 24, 2019 The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study. Atherosclerosis. 2019;282:154-161 Lazaros G, Oikonomou E, Vogiatzi G, Christoforatou E, Tsalamandris S, Goliopoulou A, Tousouli M, Mystakidou V, Chasikidis C, Tousoulis D Key Publications
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease. Atherosclerosis. 2019;281:17-24 June 19, 2019 Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease. Atherosclerosis. 2019;281:17-24 Dittrich J, Beutner F, Teren A, Thiery J, Burkhardt R, Scholz M, Ceglarek U Key Publications
Moving targets: Recent advances in lipid-lowering therapies. Arterioscler Thromb Vasc Biol. 2019;39:349-359. June 17, 2019 Moving targets: Recent advances in lipid-lowering therapies. Arterioscler Thromb Vasc Biol. 2019;39:349-359. Larsen LE, Stoekenbroek RM, Kastelein JJP, Holleboom AG Key Publications
Evaluating the potential association between lipoprotein(a) and atherosclerosis (from the mediators of atherosclerosis among South Asians living in America cohort). Am J Cardiol. 2019;123:919-921 June 12, 2019 Evaluating the potential association between lipoprotein(a) and atherosclerosis (from the mediators of atherosclerosis among South Asians living in America cohort). Am J Cardiol. 2019;123:919-921 Huffman MD, Kandula NR, Baldridge AS, Tsai MY, Prabhakaran D, Kanaya AM Key Publications
Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study. Nutr Metab Cardiovasc Dis. 2019;29:228-235 June 07, 2019 Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study. Nutr Metab Cardiovasc Dis. 2019;29:228-235 Kowall B, Lehmann N, Mahabadi AA, Moebus S, Erbel R, Jöckel KH, Stang A Key Publications
Steps per day and arterial stiffness. Hypertension. 2019;73:350-363 May 23, 2019 Steps per day and arterial stiffness. Hypertension. 2019;73:350-363 Cavero-Redondo I, Tudor-Locke C, Álvarez-Bueno C, Cunha PG, Aguiar EJ, Martínez-Vizcaíno V Key Publications
Never too old for statin treatment? Lancet. 2019 2;393:379-380 May 21, 2019 Never too old for statin treatment? Lancet. 2019 2;393:379-380 Cheung BMY, Lam KSL Key Publications

  of 103 Next page

Go to page: of